Catalyst Wire Dossier Catalyst Wire Dossier

Zelquistinel

Zelquistinel · Syndeio Biosciences, Inc
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Zelquistinel, covering 2022-08-02 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder [Phase 2]

See pricing